Label-free and high-throughput removal of residual undifferentiated cells from iPSC-derived spinal cord progenitor cells
The transplantation of spinal cord progenitor cells (SCPCs) derived from human-induced pluripotent stem cells (iPSCs) has beneficial effects in treating spinal cord injury (SCI). However, the presence of residual undifferentiated iPSCs among their differentiated progeny poses a high risk as these ce...
Main Authors: | , , , , , , , , , |
---|---|
מחברים אחרים: | |
פורמט: | Journal Article |
שפה: | English |
יצא לאור: |
2024
|
נושאים: | |
גישה מקוונת: | https://hdl.handle.net/10356/179447 |